title: Understanding the mechanism of hepatic fibrosis and potential therapeutic approaches.
abstract: Hepatic fibrosis (HF) is a progressive condition with serious clinical complications arising from abnormal proliferation and amassing of tough fibrous scar tissue. This defiance of collagen fibers becomes fatal due to ultimate failure of liver functions. Participation of various cell types, interlinked cellular events, and large number of mediator molecules make the fibrotic process enormously complex and dynamic. However, with better appreciation of underlying cellular and molecular mechanisms of fibrosis, the assumption that HF cannot be cured is gradually changing. Recent findings have underlined the therapeutic potential of a number of synthetic compounds as well as plant derivatives for cessation or even the reversal of the processes that transforms the liver into fibrotic tissue. It is expected that future inputs will provide a conceptual framework to develop more specific strategies that would facilitate the assessment of risk factors, shortlist early diagnosis biomarkers, and eventually guide development of effective therapeutic alternatives.
authors.affiliation: Department of Zoology, Biochemical and Clinical Genetics Research Laboratory, Section of Genetics, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.
authors.forename: Areeba
authors.initials: A
authors.lastname: Ahmad
authors.forename: Riaz
authors.initials: R
authors.lastname: Ahmad
mesh_terms: D015415:Biomarkers / Q000378:metabolism; D003094:Collagen / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D018450:Disease Progression; D015316:Genetic Therapy; D006801:Humans; D008099:Liver / Q000166:cytology / Q000473:pathology; D008103:Liver Cirrhosis / Q000209:etiology / Q000378:metabolism / Q000473:pathology* / Q000628:therapy*; D020011:Protective Agents / Q000494:pharmacology; D012307:Risk Factors
chemical_list: D015415:Biomarkers; D016207:Cytokines; D020011:Protective Agents; D003094:Collagen